Viewing Study NCT04061850


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2025-12-26 @ 7:22 AM
Study NCT ID: NCT04061850
Status: COMPLETED
Last Update Posted: 2020-10-22
First Post: 2019-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module